A phase III study of neoadjuvant bicalutamide in patients with intermediate risk prostate cancer undergoing radiation therapy
Latest Information Update: 29 Jan 2010
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 14 Feb 2006 New trial record.